Sanara MedTech Net Profit Margin 2014-2025 | SMTI
Sanara MedTech net profit margin from 2014 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Sanara MedTech Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.09B | $-0.01B | -14.29% |
| 2024-12-31 | $0.09B | $-0.01B | -12.64% |
| 2024-09-30 | $0.08B | $-0.01B | -11.39% |
| 2024-06-30 | $0.07B | $-0.01B | -9.59% |
| 2024-03-31 | $0.07B | $-0.01B | -7.25% |
| 2023-12-31 | $0.07B | $0.00B | -6.06% |
| 2023-09-30 | $0.06B | $-0.01B | -12.70% |
| 2023-06-30 | $0.06B | $-0.01B | -13.33% |
| 2023-03-31 | $0.05B | $-0.01B | -9.26% |
| 2022-12-31 | $0.05B | $-0.01B | -15.22% |
| 2022-09-30 | $0.04B | $-0.01B | -18.42% |
| 2022-06-30 | $0.03B | $-0.01B | -25.81% |
| 2022-03-31 | $0.03B | $-0.01B | -37.04% |
| 2021-12-31 | $0.02B | $-0.01B | -33.33% |
| 2021-09-30 | $0.02B | $0.00B | -18.18% |
| 2021-06-30 | $0.02B | $0.00B | -15.00% |
| 2021-03-31 | $0.02B | $0.00B | -17.65% |
| 2020-12-31 | $0.02B | $0.00B | -25.00% |
| 2020-09-30 | $0.01B | $-0.01B | -35.71% |
| 2020-06-30 | $0.01B | $-0.01B | -38.46% |
| 2020-03-31 | $0.01B | $0.00B | -30.77% |
| 2019-12-31 | $0.01B | $0.00B | -18.18% |
| 2019-09-30 | $0.01B | $0.00B | -10.00% |
| 2019-06-30 | $0.01B | 0 | 0.00% |
| 2019-03-31 | $0.01B | 0 | 0.00% |
| 2018-12-31 | $0.01B | 0 | 0.00% |
| 2018-09-30 | $0.01B | 0 | 0.00% |
| 2018-06-30 | $0.01B | 0 | 0.00% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-03-31 | $0.00B | $0.00B | -33.33% |
| 2016-06-30 | $0.00B | $0.00B | -33.33% |
| 2016-03-31 | $0.00B | $0.00B | -33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.274B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.294B | 27.81 |
| Boston Scientific (BSX) | United States | $157.073B | 39.32 |
| Stryker (SYK) | United States | $146.485B | 30.63 |
| EssilorLuxottica (ESLOY) | France | $131.510B | 0.00 |
| Medtronic (MDT) | Ireland | $104.117B | 14.76 |
| Haleon (HLN) | United Kingdom | $50.587B | 28.80 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.544B | 0.00 |
| ResMed (RMD) | United States | $36.103B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $32.514B | 15.44 |
| Agilent Technologies (A) | United States | $31.721B | 20.95 |
| Terumo (TRUMY) | Japan | $28.131B | 36.54 |
| Insulet (PODD) | United States | $22.987B | 90.23 |
| Koninklijke Philips (PHG) | Netherlands | $21.694B | 15.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.639B | 11.97 |
| Baxter (BAX) | United States | $15.842B | 11.83 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.666B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.269B | 21.81 |
| Lantheus Holdings (LNTH) | United States | $5.242B | 13.22 |
| Prestige Consumer Healthcare (PBH) | United States | $4.244B | 18.96 |
| Perrigo (PRGO) | Ireland | $3.757B | 9.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.266B | 14.88 |
| ICU Medical (ICUI) | United States | $3.210B | 23.67 |
| Envista Holdings (NVST) | United States | $3.051B | 25.35 |
| GN Store Nord (GNNDY) | Denmark | $2.163B | 17.92 |
| QuidelOrtho (QDEL) | United States | $2.114B | 14.54 |
| LeMaitre Vascular (LMAT) | United States | $1.868B | 41.76 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Neogen (NEOG) | United States | $1.335B | 17.08 |
| Acuren (TIC) | United States | $1.317B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.256B | 12.75 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| CeriBell (CBLL) | United States | $0.625B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.590B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Owens & Minor (OMI) | United States | $0.509B | 4.22 |
| Capricor Therapeutics (CAPR) | United States | $0.479B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.446B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.307B | 54.70 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.11 |
| Cerus (CERS) | United States | $0.241B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| Quanterix (QTRX) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.46 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.69 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Agape ATP (ATPC) | $0.092B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.42 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.47 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.86 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |